EAHP represents over 29,000 hospital pharmacists across 36 member countries. EAHP represents and develops the hospital pharmacy profession within Europe in order to ensure the continuous improvement of care and outcomes for patients in the hospital setting. This is achieved through science, research, education, practice, as well as sharing best-practice and responsibility with other healthcare professionals.
The EAHP Board, elected for three-year terms, oversees the association’s activities. Comprising directors responsible for core functions, it meets regularly to implement strategic goals. Supported by EAHP staff, the Board controls finances, coordinates congress organization, and ensures compliance with statutes and codes of conduct.
The EAHP staff supports the Board in executing EAHP’s mission. The Staff assists in financial management, events organisations, policy activities and all EAHP projects. The EAHP staff works closely with EAHP’s members and ensures the effective communication all relevant stakeholders.
The first member countries were Belgium, Britain, Denmark, France, the Federal Republic of Germany and The Netherlands in 1972. EAHP has now 36 EAHP members and 2 Associate Members. EAHP is open to countries members of the Council of Europe and since 2022 to organisations representing the interests of hospital pharmacists from outside the Council of Europe (Associate Membership)
EAHP’s structure is also composed by different standing committes: EAHP Scientific Committee, EAHP Education Executive Committee and the EAHP CTF Steering Committee.
At EAHP, we are committed to transparency in our governance, ethical standards, and funding practices. This section provides open access to our foundational documents, including the EAHP Statutes, Code of Conduct, and Funding Sources. By sharing these resources, we aim to uphold accountability and foster trust with our members, partners, and the public.
Keep up with all EAHP’s events and webinars. Contact the team at info@eahp.eu should you have any questions about upcoming events or activities.
Here you can find all upcoming events organised by EAHP and by all its members and associate members. Do not hesitate to contact the events team at events@eahp.eu should you have any questions about the organisation of these events.
Hospital pharmacists conduct a critical role in the care of patients in hospitals. Learn more about what they do here and in all the pages under Hospital Pharmacy practice and Policy.
Self-Assessment
SILCC
Closed SIGs
EAHP brings together experts from many areas of hospital pharmacy practice providing and highlighting good local sustainable practices as that can be up-scaled and shared with other countries. The EAHP Working Group on Sustainability has the aim of reducing the environmental burden of the hospital pharmacy services.
The European Association of Hospital Pharmacists (EAHP), and its 36 member country platforms are creating a Common Training Framework for the hospital pharmacy education in Europe. The goal of this project is to allow the free movement of hospital pharmacists within the European Union.
The European Association of Hospital Pharmacists (EAHP) and the European Society of Clinical Pharmacy (ESCP) have collaboratively developed the Oath to Society. The Oath to Society is all encompassing and acts as a contract for excellence in providing compassionate patient care, working as part of the healthcare team and advancing the pharmacy profession, and showcasing how clinical and hospital pharmacists work every day
A day created to highlight the importance and to celebrate the work done by hospital pharmacies. This day celebrates all hospital pharmacy teams.
Catch up with EAHP’s press releases
Find all EAHP relevant publication like the EAHP Surveys, annual reports and the history books.
The European Journal of Hospital Pharmacy (EJHP) is the only official journal of the European Association of Hospital Pharmacists (EAHP) and is committed to advancing the science, practice and profession of hospital pharmacy. As the premier communication platform for hospital pharmacists worldwide, EJHP is a major source for continuing education as well as updates on advances in the practice and standard of pharmaceutical care for patients.
When EAHP and Hospital pharmacists appear in the news.
EAHP publishes a monthly EU monitor with updates about the latest EAHP initiatives and information relevant for the hospital pharmacy profession.
Sponsor Channel
The Sponsor Channel is designed to maximise visibility and engagement, allowing sponsors to connect with the hospital pharmacy community and partners in a dynamic and interactive environment. From product demonstrations to networking sessions, the Sponsor Channel offers a range of opportunities for sponsors to showcase their offerings and generate leads in the new EAHP Website.
Healthcare workers, including doctors, pharmacists and nurses, are attending daily to the needs of Europe’s COVID-19 patients. Those patients requiring intubation also need to follow a concomitant therapy for which the use of anaesthetics, antibiotics and muscle relaxants is essential. Also, other supportive medicines needed in intensive care units, like resuscitation, respiratory and cardiac medicines, analgesics, medicines for thromboprophylaxis as well as medical nutrition and large volume parenterals are indispensable. The demand for these medicines has significantly increased in the past weeks, in particular in countries heavily affected by the pandemic.
In light of growing demand for certain types of medicines, issues linked to shortages have aggravated. In combination with transportation and export barriers between countries, lower production in Europe and supply problems for medicines and active pharmaceutical ingredients (API) sourced outside of Europe, treatment options are becoming more and more limited in certain regions. We consequently encourage European countries to adopt measures similar to those taken in France and the Netherlands, where stock levels for medicines needed for the treatment of COVID-19 patients are being monitored and allocated according to need by the national hospital pharmacy association/with the help of a dedicated application. Only knowledge about the situation can help safeguard the adequate distribution of stocks among hospitals in accordance with the number of patients they are serving.
We welcome the efforts that are being undertaken by our colleagues across Europe in search of a treatment for the coronavirus. Physicians and pharmacists, in general, shall follow the principles of evidence-based medicine. Therefore, we ask our colleagues to closely monitor and evaluate emerging clinical and research data to make use of evidence informed practices when weighing the risks and benefits for each individual case, in particular when using medications for an unapproved indication. Also, we urge those colleagues, that have the capacity, to participate in research activities to facilitate the generation and sharing of the much needed evidence for the optimisation of treatment for COVID-19 patients. Concerning the recourse to treatment options already licensed for indications other than the treatment of COVID-19 patients, we also would like to raise additional concerns. We call on our colleagues as well as on national governments and competent authorities to ensure that stockpiling and anticipatory orders for certain medicines used currently off label in COVID-19 patients do not affect the treatment of patients already taking these medications.
Given the need for European-wide collaboration, we appreciate the steps that are being taken by the EU authorities, in particular those that increase the involvement of the European Medicines Agency (EMA) to support the availability of medicines used in the COVID-19 pandemic. Besides letting EMA become a central coordinator, we would also like to encourage national governments and competent authorities to take the necessary measures that go beyond mere exchange which will guarantee the availability of essential medicines throughout the Union.
For further information contact info@eahp.eu | 00 322 669 2513
The list of the organisations signing the statement:
